AstraZeneca acquires Hamilton-based pharmaceutical company Fusion

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

A Canadian pharmaceutical company that focuses on developing next-generation therapies for prostate cancer has announced a definitive agreement to be acquired by U.K.-based AstraZeneca for approximately US$2.4 billion.

AstraZeneca acquires Hamilton-based pharmaceutical company FusionEQT CEO Warns Lack of Gas Storage Will Trigger Price GyrationsApollo Targets at Least $6 Billion for Third Hybrid Value FundAI Hype Hurts Emerging Markets, BTG Billionaire Esteves SaysUK Farmers to Drive Tractors to London to Protest Food PoliciesSupreme Court Allows Texas Deportation Law in Biden LossChina’s Builders Tackle Restructuring as Crisis Enters New PhaseMicrosoft Hires DeepMind Co-Founder Suleyman to Run Consumer AIUS...

6 ChargesSupreme Court Allows Texas Deportation Law in Biden LossTrump Says He Is ‘100%’ Behind NATO Allies Who Hit Spending GoalDoug Emhoff Decries ‘Antisemitic’ Trump Comments on Jewish DemocratsSenegal’s Sall Says Democracy Intact After Delayed Vote TurmoilBiden and Bibi Back Off Their Feud But Suspicion Lingers at HomeSouth African Investigators Raid Residence of Parliament SpeakerChinese Businessman Qin Hui Pleads Guilty to Straw Donor SchemeHunt Hints UK Government Looking at October for...

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 83. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し